Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

83.76 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Why Is DexCom (DXCM) Stock Down 38% Today?
DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance. 
Via InvestorPlace
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
This Southwest Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Dexcom Shares Plummet Nearly 39% In Pre-Market After Lowering Full-Year Sales Outlook
During an analyst call, Dexcom executives attributed the forecast cut to fewer new customers and lower revenue per customer than expected. 
Via Benzinga
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued... 
Via Benzinga
Topics Economy
$100 Invested In DexCom 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday! 
Via InvestorPlace
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook. 
Via Benzinga
Get Your Money Out of These 3 Nasdaq Stocks by the End of July
Discover why these three Nasdaq stocks may be worth selling at their current price levels. 
Via InvestorPlace
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.
DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
Via Chartmill
What Analysts Are Saying About DexCom Stock
Via Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
DexCom (DXCM) Q2 2024 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Thursday, major U.S. indices showed mixed results. The Dow Jones Industrial Average increased by 0.2% to 39,935.07. 
Via Benzinga
Topics Stocks
DXCM Stock Earnings: DexCom Beats EPS, Misses Revenue for Q2 2024
DXCM stock results show that DexCom beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Dexcom Stock Collapses 33% After Sales Miss Leads To $25 Million Guidance Cut
Shares are poised to open Friday at their lowest point since April 2022. 
Via Investor's Business Daily
Topics Earnings
Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On
Nasdaq 100 index falls to its lowest level since June amid volatility. Despite a brief boost from Q2 GDP growth and decreasing prices, it dropped 4.7% in 2 sessions. 
Via Benzinga
Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase.
Why DEXCOM INC (NASDAQ:DXCM) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today
Via Benzinga
DexCom Stock Drops After Mixed Q2 Results, Weak Forward Guidance
DexCom shares are dropping after the company reported its second-quarter financial results Thursday. Here's a look at the key figures from the report. 
Via Benzinga
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
Via Benzinga
2 Healthcare Stocks to Buy at a Discount
Beaten-down stocks can sometimes present an opportunity. 
Via The Motley Fool
3 Breakthrough Medical Device Stocks to Invest In Now
Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead. 
Via InvestorPlace
2 Top Growth Stocks to Buy With $1,000
These stocks have excellent track records of beating the market. 
Via The Motley Fool
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact. 
Via InvestorPlace
Peering Into DexCom's Recent Short Interest
Via Benzinga
Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
Learn why DexCom, TransDigm, and Datadog, three hyped stocks trading at rich valuations, may not be the best additions to your portfolio. 
Via InvestorPlace
The 3 Best Diabetes Stocks to Buy in June 2024
There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy. 
Via InvestorPlace
What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024)
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.